This report provides a comprehensive analysis of the global bacteriophages (phage) products market, projecting growth trends through 2032. As specialized viruses capable of combating multi-drug resistant bacteria, phages are gaining traction across diverse applications, including animal health, aquaculture, agriculture, and the food industry. The study examines market dynamics by product type and geography, while profiling key industry players. It offers strategic insights into regional developments, competitive landscapes, and emerging opportunities within this accelerating biological sector.

Executive Overview

The global Bacteriophages (Phage) Products market is projected to experience significant growth from 2025 through 2032, expanding at a steady compound annual growth rate over the forecast period.

Product Definition and Utility

Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. As the most common biological entities in nature, they have demonstrated the ability to effectively fight and destroy multi-drug resistant bacteria. Notably, phages can succeed in killing bacteria and potentially saving lives from infections even in instances where all antibiotics fail.

Regional Market Analysis

Global Outlook

The global Bacteriophages (Phage) Products market is expected to undergo consistent expansion between 2025 and 2032.

United States

The United States market for Bacteriophages (Phage) Products is estimated to increase steadily from 2025 through 2032, maintaining a positive compound annual growth rate.

China

The China market for Bacteriophages (Phage) Products is estimated to see growth from 2025 through 2032, following a consistent compound annual growth rate.

Europe

The Europe market for Bacteriophages (Phage) Products is estimated to expand from 2025 through 2032, characterized by a sustained compound annual growth rate.

Market Segmentation

By Type

• DsDNA Type
• SsDNA Type
• SsRNA Type
• Others

By Application

• Animal Health
• Aquaculture
• Agriculture
• Food Industry
• Others

By Region

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

Competitive Landscape

Market Dynamics

In terms of revenue, the global market features two dominant companies that held a significant portion of the market share in 2025. The report highlights key trends regarding company formation, revenue, market share, latest developments, and M&A activity.

Key Players

The following companies have been profiled based on primary expert input and analysis of their coverage, product portfolios, and market penetration:

• Proteon Pharmaceuticals
• Phagelux
• Intralytix
• Micreos
• Eliava BioPreparations
• Locus Biosciences, Inc
• Pharmex Group, LLC
• Pherecydes Pharma
• APS Biocontrol Ltd. (APS)
• Qingdao Phagepharm Bio-tech
• Fixed-Phage Limited
• Zeptometrix
• Phage International, Inc.
• MicroMir
• iNtODEWORLD, Inc.
• NEXTBIOTICS
• Armata Pharmaceuticals, Inc.
• Innophage
• Adaptive Phage Therapeutics
• TechnoPhage

Research Methodology & Report Scope

About the Report

LP Information, Inc. (LPI)'s newest research report, the “Bacteriophages (Phage) Products Industry Forecast,” reviews total global Bacteriophages (Phage) Products sales in 2025. It provides a comprehensive analysis by region and market sector of projected sales for the period of 2026 through 2032. The study provides detailed analysis in US$ millions, breaking down sales by region, market sector, and sub-sector.

Analytical Depth

This Insight Report provides a comprehensive analysis of the global landscape, evaluating key market trends, drivers, and affecting factors. It analyzes the strategies of leading global companies, focusing on:

• Bacteriophages (Phage) Products portfolios and capabilities
• Market entry strategies
• Market positions
• Geographic footprints

Using a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study offers a highly nuanced view of the current state and future trajectory of the industry, highlighting emerging pockets of opportunity.

Key Questions Addressed

• What is the 10-year outlook for the global Bacteriophages (Phage) Products market?
• What factors are driving Bacteriophages (Phage) Products market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Bacteriophages (Phage) Products market opportunities vary by end market size?
• How does Bacteriophages (Phage) Products break out by Type and by Application?

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Bacteriophages (Phage) Products Annual Sales 2021-2032

    • 2.1.2 World Current & Future Analysis for Bacteriophages (Phage) Products by Geographic Region, 2021, 2025 & 2032

    • 2.1.3 World Current & Future Analysis for Bacteriophages (Phage) Products by Country/Region, 2021, 2025 & 2032

  • 2.2 Bacteriophages (Phage) Products Segment by Type

    • 2.2.1 DsDNA Type

    • 2.2.2 SsDNA Type

    • 2.2.3 SsRNA Type

    • 2.2.4 Others

    • 2.2.5 Bacteriophages (Phage) Products Sales by Type

      • 2.2.5.1 Global Bacteriophages (Phage) Products Sales Market Share by Type (2021-2026)
      • 2.2.5.2 Global Bacteriophages (Phage) Products Revenue and Market Share by Type (2021-2026)
      • 2.2.5.3 Global Bacteriophages (Phage) Products Sale Price by Type (2021-2026)

  • 2.3 Bacteriophages (Phage) Products Segment by Application

    • 2.3.1 Animal Health

    • 2.3.2 Aquaculture

    • 2.3.3 Agriculture

    • 2.3.4 Food Industry

    • 2.3.5 Others

    • 2.3.6 Bacteriophages (Phage) Products Sales by Application

      • 2.3.6.1 Global Bacteriophages (Phage) Products Sale Market Share by Application (2021-2026)
      • 2.3.6.2 Global Bacteriophages (Phage) Products Revenue and Market Share by Application (2021-2026)
      • 2.3.6.3 Global Bacteriophages (Phage) Products Sale Price by Application (2021-2026)

• 3 Global by Company

  • 3.1 Global Bacteriophages (Phage) Products Breakdown Data by Company

    • 3.1.1 Global Bacteriophages (Phage) Products Annual Sales by Company (2021-2026)

    • 3.1.2 Global Bacteriophages (Phage) Products Sales Market Share by Company (2021-2026)

  • 3.2 Global Bacteriophages (Phage) Products Annual Revenue by Company (2021-2026)

    • 3.2.1 Global Bacteriophages (Phage) Products Revenue by Company (2021-2026)

    • 3.2.2 Global Bacteriophages (Phage) Products Revenue Market Share by Company (2021-2026)

  • 3.3 Global Bacteriophages (Phage) Products Sale Price by Company

  • 3.4 Key Manufacturers Bacteriophages (Phage) Products Producing Area Distribution, Sales Area, Product Type

    • 3.4.1 Key Manufacturers Bacteriophages (Phage) Products Product Location Distribution

    • 3.4.2 Players Bacteriophages (Phage) Products Products Offered

  • 3.5 Market Concentration Rate Analysis

    • 3.5.1 Competition Landscape Analysis

    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.6 New Products and Potential Entrants

  • 3.7 Market M&A Activity & Strategy

• 4 World Historic Review for Bacteriophages (Phage) Products by Geographic Region

  • 4.1 World Historic Bacteriophages (Phage) Products Market Size by Geographic Region (2021-2026)

    • 4.1.1 Global Bacteriophages (Phage) Products Annual Sales by Geographic Region (2021-2026)

    • 4.1.2 Global Bacteriophages (Phage) Products Annual Revenue by Geographic Region (2021-2026)

  • 4.2 World Historic Bacteriophages (Phage) Products Market Size by Country/Region (2021-2026)

    • 4.2.1 Global Bacteriophages (Phage) Products Annual Sales by Country/Region (2021-2026)

    • 4.2.2 Global Bacteriophages (Phage) Products Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Bacteriophages (Phage) Products Sales Growth

  • 4.4 APAC Bacteriophages (Phage) Products Sales Growth

  • 4.5 Europe Bacteriophages (Phage) Products Sales Growth

  • 4.6 Middle East & Africa Bacteriophages (Phage) Products Sales Growth

• 5 Americas

  • 5.1 Americas Bacteriophages (Phage) Products Sales by Country

    • 5.1.1 Americas Bacteriophages (Phage) Products Sales by Country (2021-2026)

    • 5.1.2 Americas Bacteriophages (Phage) Products Revenue by Country (2021-2026)

  • 5.2 Americas Bacteriophages (Phage) Products Sales by Type (2021-2026)

  • 5.3 Americas Bacteriophages (Phage) Products Sales by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Bacteriophages (Phage) Products Sales by Region

    • 6.1.1 APAC Bacteriophages (Phage) Products Sales by Region (2021-2026)

    • 6.1.2 APAC Bacteriophages (Phage) Products Revenue by Region (2021-2026)

  • 6.2 APAC Bacteriophages (Phage) Products Sales by Type (2021-2026)

  • 6.3 APAC Bacteriophages (Phage) Products Sales by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

  • 6.10 China Taiwan

• 7 Europe

  • 7.1 Europe Bacteriophages (Phage) Products by Country

    • 7.1.1 Europe Bacteriophages (Phage) Products Sales by Country (2021-2026)

    • 7.1.2 Europe Bacteriophages (Phage) Products Revenue by Country (2021-2026)

  • 7.2 Europe Bacteriophages (Phage) Products Sales by Type (2021-2026)

  • 7.3 Europe Bacteriophages (Phage) Products Sales by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Bacteriophages (Phage) Products by Country

    • 8.1.1 Middle East & Africa Bacteriophages (Phage) Products Sales by Country (2021-2026)

    • 8.1.2 Middle East & Africa Bacteriophages (Phage) Products Revenue by Country (2021-2026)

  • 8.2 Middle East & Africa Bacteriophages (Phage) Products Sales by Type (2021-2026)

  • 8.3 Middle East & Africa Bacteriophages (Phage) Products Sales by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers

  • 10.2 Manufacturing Cost Structure Analysis of Bacteriophages (Phage) Products

  • 10.3 Manufacturing Process Analysis of Bacteriophages (Phage) Products

  • 10.4 Industry Chain Structure of Bacteriophages (Phage) Products

• 11 Marketing, Distributors and Customer

  • 11.1 Sales Channel

    • 11.1.1 Direct Channels

    • 11.1.2 Indirect Channels

  • 11.2 Bacteriophages (Phage) Products Distributors

  • 11.3 Bacteriophages (Phage) Products Customer

• 12 World Forecast Review for Bacteriophages (Phage) Products by Geographic Region

  • 12.1 Global Bacteriophages (Phage) Products Market Size Forecast by Region

    • 12.1.1 Global Bacteriophages (Phage) Products Forecast by Region (2027-2032)

    • 12.1.2 Global Bacteriophages (Phage) Products Annual Revenue Forecast by Region (2027-2032)

  • 12.2 Americas Forecast by Country (2027-2032)

  • 12.3 APAC Forecast by Region (2027-2032)

  • 12.4 Europe Forecast by Country (2027-2032)

  • 12.5 Middle East & Africa Forecast by Country (2027-2032)

  • 12.6 Global Bacteriophages (Phage) Products Forecast by Type (2027-2032)

  • 12.7 Global Bacteriophages (Phage) Products Forecast by Application (2027-2032)

• 13 Key Players Analysis

  • 13.1 Proteon Pharmaceuticals

    • 13.1.1 Proteon Pharmaceuticals Company Information

    • 13.1.2 Proteon Pharmaceuticals Bacteriophages (Phage) Products Product Portfolios and Specifications

    • 13.1.3 Proteon Pharmaceuticals Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.1.4 Proteon Pharmaceuticals Main Business Overview

    • 13.1.5 Proteon Pharmaceuticals Latest Developments

  • 13.2 Phagelux

    • 13.2.1 Phagelux Company Information

    • 13.2.2 Phagelux Bacteriophages (Phage) Products Product Portfolios and Specifications

    • 13.2.3 Phagelux Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.2.4 Phagelux Main Business Overview

    • 13.2.5 Phagelux Latest Developments

  • 13.3 Intralytix

    • 13.3.1 Intralytix Company Information

    • 13.3.2 Intralytix Bacteriophages (Phage) Products Product Portfolios and Specifications

    • 13.3.3 Intralytix Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.3.4 Intralytix Main Business Overview

    • 13.3.5 Intralytix Latest Developments

  • 13.4 Micreos

    • 13.4.1 Micreos Company Information

    • 13.4.2 Micreos Bacteriophages (Phage) Products Product Portfolios and Specifications

    • 13.4.3 Micreos Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.4.4 Micreos Main Business Overview

    • 13.4.5 Micreos Latest Developments

  • 13.5 Eliava BioPreparations

    • 13.5.1 Eliava BioPreparations Company Information

    • 13.5.2 Eliava BioPreparations Bacteriophages (Phage) Products Product Portfolios and Specifications

    • 13.5.3 Eliava BioPreparations Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.5.4 Eliava BioPreparations Main Business Overview

    • 13.5.5 Eliava BioPreparations Latest Developments

  • 13.6 Locus Biosciences,Inc

    • 13.6.1 Locus Biosciences,Inc Company Information

    • 13.6.2 Locus Biosciences,Inc Bacteriophages (Phage) Products Product Portfolios and Specifications

    • 13.6.3 Locus Biosciences,Inc Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.6.4 Locus Biosciences,Inc Main Business Overview

    • 13.6.5 Locus Biosciences,Inc Latest Developments

  • 13.7 Pharmex Group,LLC

    • 13.7.1 Pharmex Group,LLC Company Information

    • 13.7.2 Pharmex Group,LLC Bacteriophages (Phage) Products Product Portfolios and Specifications

    • 13.7.3 Pharmex Group,LLC Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.7.4 Pharmex Group,LLC Main Business Overview

    • 13.7.5 Pharmex Group,LLC Latest Developments

  • 13.8 Pherecydes Pharma

    • 13.8.1 Pherecydes Pharma Company Information

    • 13.8.2 Pherecydes Pharma Bacteriophages (Phage) Products Product Portfolios and Specifications

    • 13.8.3 Pherecydes Pharma Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.8.4 Pherecydes Pharma Main Business Overview

    • 13.8.5 Pherecydes Pharma Latest Developments

  • 13.9 APS Biocontrol Ltd. (APS)

    • 13.9.1 APS Biocontrol Ltd. (APS) Company Information

    • 13.9.2 APS Biocontrol Ltd. (APS) Bacteriophages (Phage) Products Product Portfolios and Specifications

    • 13.9.3 APS Biocontrol Ltd. (APS) Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.9.4 APS Biocontrol Ltd. (APS) Main Business Overview

    • 13.9.5 APS Biocontrol Ltd. (APS) Latest Developments

  • 13.10 Qingdao Phagepharm Bio-tech

    • 13.10.1 Qingdao Phagepharm Bio-tech Company Information

    • 13.10.2 Qingdao Phagepharm Bio-tech Bacteriophages (Phage) Products Product Portfolios and Specifications

    • 13.10.3 Qingdao Phagepharm Bio-tech Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.10.4 Qingdao Phagepharm Bio-tech Main Business Overview

    • 13.10.5 Qingdao Phagepharm Bio-tech Latest Developments

  • 13.11 Fixed-Phage Limited

    • 13.11.1 Fixed-Phage Limited Company Information

    • 13.11.2 Fixed-Phage Limited Bacteriophages (Phage) Products Product Portfolios and Specifications

    • 13.11.3 Fixed-Phage Limited Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.11.4 Fixed-Phage Limited Main Business Overview

    • 13.11.5 Fixed-Phage Limited Latest Developments

  • 13.12 Zeptometrix

    • 13.12.1 Zeptometrix Company Information

    • 13.12.2 Zeptometrix Bacteriophages (Phage) Products Product Portfolios and Specifications

    • 13.12.3 Zeptometrix Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.12.4 Zeptometrix Main Business Overview

    • 13.12.5 Zeptometrix Latest Developments

  • 13.13 Phage International, Inc.

    • 13.13.1 Phage International, Inc. Company Information

    • 13.13.2 Phage International, Inc. Bacteriophages (Phage) Products Product Portfolios and Specifications

    • 13.13.3 Phage International, Inc. Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.13.4 Phage International, Inc. Main Business Overview

    • 13.13.5 Phage International, Inc. Latest Developments

  • 13.14 MicroMir

    • 13.14.1 MicroMir Company Information

    • 13.14.2 MicroMir Bacteriophages (Phage) Products Product Portfolios and Specifications

    • 13.14.3 MicroMir Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.14.4 MicroMir Main Business Overview

    • 13.14.5 MicroMir Latest Developments

  • 13.15 iNtODEWORLD, Inc.

    • 13.15.1 iNtODEWORLD, Inc. Company Information

    • 13.15.2 iNtODEWORLD, Inc. Bacteriophages (Phage) Products Product Portfolios and Specifications

    • 13.15.3 iNtODEWORLD, Inc. Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.15.4 iNtODEWORLD, Inc. Main Business Overview

    • 13.15.5 iNtODEWORLD, Inc. Latest Developments

  • 13.16 NEXTBIOTICS

    • 13.16.1 NEXTBIOTICS Company Information

    • 13.16.2 NEXTBIOTICS Bacteriophages (Phage) Products Product Portfolios and Specifications

    • 13.16.3 NEXTBIOTICS Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.16.4 NEXTBIOTICS Main Business Overview

    • 13.16.5 NEXTBIOTICS Latest Developments

  • 13.17 Armata Pharmaceuticals, Inc.

    • 13.17.1 Armata Pharmaceuticals, Inc. Company Information

    • 13.17.2 Armata Pharmaceuticals, Inc. Bacteriophages (Phage) Products Product Portfolios and Specifications

    • 13.17.3 Armata Pharmaceuticals, Inc. Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.17.4 Armata Pharmaceuticals, Inc. Main Business Overview

    • 13.17.5 Armata Pharmaceuticals, Inc. Latest Developments

  • 13.18 Innophage

    • 13.18.1 Innophage Company Information

    • 13.18.2 Innophage Bacteriophages (Phage) Products Product Portfolios and Specifications

    • 13.18.3 Innophage Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.18.4 Innophage Main Business Overview

    • 13.18.5 Innophage Latest Developments

  • 13.19 Adaptive Phage Therapeutics

    • 13.19.1 Adaptive Phage Therapeutics Company Information

    • 13.19.2 Adaptive Phage Therapeutics Bacteriophages (Phage) Products Product Portfolios and Specifications

    • 13.19.3 Adaptive Phage Therapeutics Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.19.4 Adaptive Phage Therapeutics Main Business Overview

    • 13.19.5 Adaptive Phage Therapeutics Latest Developments

  • 13.20 TechnoPhage

    • 13.20.1 TechnoPhage Company Information

    • 13.20.2 TechnoPhage Bacteriophages (Phage) Products Product Portfolios and Specifications

    • 13.20.3 TechnoPhage Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.20.4 TechnoPhage Main Business Overview

    • 13.20.5 TechnoPhage Latest Developments

• 14 Research Findings and Conclusion